432 related articles for article (PubMed ID: 26607133)
1. Plasma atrial natriuretic peptide and N-terminal pro B-type natriuretic peptide concentrations in dogs with right-sided congestive heart failure.
Kanno N; Hori Y; Hidaka Y; Chikazawa S; Kanai K; Hoshi F; Itoh N
J Vet Med Sci; 2016 May; 78(4):535-42. PubMed ID: 26607133
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of circulating amino terminal-pro-B-type natriuretic peptide concentration in dogs with respiratory distress attributable to congestive heart failure or primary pulmonary disease.
Fine DM; DeClue AE; Reinero CR
J Am Vet Med Assoc; 2008 Jun; 232(11):1674-9. PubMed ID: 18518809
[TBL] [Abstract][Full Text] [Related]
3. Relationship of plasma N-terminal pro-brain natriuretic peptide concentrations to heart failure classification and cause of respiratory distress in dogs using a 2nd generation ELISA assay.
Fox PR; Oyama MA; Hezzell MJ; Rush JE; Nguyenba TP; DeFrancesco TC; Lehmkuhl LB; Kellihan HB; Bulmer B; Gordon SG; Cunningham SM; MacGregor J; Stepien RL; Lefbom B; Adin D; Lamb K
J Vet Intern Med; 2015 Jan; 29(1):171-9. PubMed ID: 25308881
[TBL] [Abstract][Full Text] [Related]
4. Comparison of N-terminal pro-atrial natriuretic peptide and three cardiac biomarkers for discriminatory ability of clinical stage in dogs with myxomatous mitral valve disease.
Ogawa M; Hori Y; Kanno N; Iwasa N; Toyofuku T; Isayama N; Yoshikawa A; Akabane R; Sakatani A; Miyakawa H; Hsu HH; Miyagawa Y; Takemura N
J Vet Med Sci; 2021 Apr; 83(4):705-715. PubMed ID: 33551383
[TBL] [Abstract][Full Text] [Related]
5. The diagnostic relevance of NT-proBNP and proANP 31-67 measurements in staging of myxomatous mitral valve disease in dogs.
Wolf J; Gerlach N; Weber K; Klima A; Wess G
Vet Clin Pathol; 2013 Jun; 42(2):196-206. PubMed ID: 23614733
[TBL] [Abstract][Full Text] [Related]
6. Utility of plasma N-terminal pro-brain natriuretic peptide (NT-proBNP) to distinguish between congestive heart failure and non-cardiac causes of acute dyspnea in cats.
Fox PR; Oyama MA; Reynolds C; Rush JE; DeFrancesco TC; Keene BW; Atkins CE; Macdonald KA; Schober KE; Bonagura JD; Stepien RL; Kellihan HB; Nguyenba TP; Lehmkuhl LB; Lefbom BK; Moise NS; Hogan DF
J Vet Cardiol; 2009 May; 11 Suppl 1():S51-61. PubMed ID: 19394287
[TBL] [Abstract][Full Text] [Related]
7. Assessment of serum N-terminal pro-B-type natriuretic peptide concentration for differentiation of congestive heart failure from primary respiratory tract disease as the cause of respiratory signs in dogs.
Oyama MA; Rush JE; Rozanski EA; Fox PR; Reynolds CA; Gordon SG; Bulmer BJ; Lefbom BK; Brown BA; Lehmkuhl LB; Prosek R; Lesser MB; Kraus MS; Bossbaly MJ; Rapoport GS; Boileau JS
J Am Vet Med Assoc; 2009 Dec; 235(11):1319-25. PubMed ID: 19951101
[TBL] [Abstract][Full Text] [Related]
8. [Comparison study on diagnostic and prognostic value of N-terminal pro-brain natriuretic peptide and atrium natriuretic peptide in chronic congestive heart failure].
Li YJ; Wang L; Chen KY; Chen YL; Cai JR; Zhou LJ
Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2005 Sep; 17(9):544-7. PubMed ID: 16146600
[TBL] [Abstract][Full Text] [Related]
9. [Diagnostic value of plasma concentration of pro-brain natriuretic peptide in congestive heart failure in pediatric patients with ventricular septal defects].
Wu YR; Chen SB; Huang MR; Zhang YQ; Sun K; Chen S
Zhonghua Er Ke Za Zhi; 2005 Mar; 43(3):161-4. PubMed ID: 15833183
[TBL] [Abstract][Full Text] [Related]
10. The diagnostic accuracy of different natriuretic peptides in the investigation of canine cardiac disease.
Boswood A; Dukes-McEwan J; Loureiro J; James RA; Martin M; Stafford-Johnson M; Smith P; Little C; Attree S
J Small Anim Pract; 2008 Jan; 49(1):26-32. PubMed ID: 18005104
[TBL] [Abstract][Full Text] [Related]
11. [Comparison study on diagnostic and prognostic value of N-terminal probrain natriuretic peptide and atrium natriuretic peptide in chronic congestive heart failure].
Dong H; Chen DQ; Wang Y; Li M
Nan Fang Yi Ke Da Xue Xue Bao; 2008 Aug; 28(9):1740-2. PubMed ID: 18819908
[TBL] [Abstract][Full Text] [Related]
12. Diagnostic utility of NT-proBNP and ANP in a canine model of chronic embolic pulmonary hypertension.
Hori Y; Uchide T; Saitoh R; Thoei D; Uchida M; Yoshioka K; Chikazawa S; Hoshi F
Vet J; 2012 Nov; 194(2):215-21. PubMed ID: 22578688
[TBL] [Abstract][Full Text] [Related]
13. Plasma N-terminal pro-B-type natriuretic peptide concentration in healthy retired racing Greyhounds.
Couto KM; Iazbik MC; Marín LM; Zaldivar-López S; Beal MJ; Gómez Ochoa P; Couto CG
Vet Clin Pathol; 2015 Sep; 44(3):405-9. PubMed ID: 25982692
[TBL] [Abstract][Full Text] [Related]
14. [Values of brain natriuretic peptide and N-terminal pro-brain natriuretic peptide in evaluation of cardiac function in children with congenital heart disease].
Zhang SR; Zhang YH; Xu Q; Qiu HX; Chen Q
Zhongguo Dang Dai Er Ke Za Zhi; 2009 Jun; 11(6):429-32. PubMed ID: 19558803
[TBL] [Abstract][Full Text] [Related]
15. Acute cardiac volume load-related changes in plasma atrial natriuretic peptide and N-terminal pro-B-type natriuretic peptide concentrations in healthy dogs.
Hori Y; Sano N; Kanai K; Hoshi F; Itoh N; Higuchi S
Vet J; 2010 Sep; 185(3):317-21. PubMed ID: 19709913
[TBL] [Abstract][Full Text] [Related]
16. Plasma N-terminal pro B-type natriuretic peptide concentrations in dogs with pulmonic stenosis.
Kobayashi K; Hori Y; Chimura S
J Vet Med Sci; 2014 Jun; 76(6):827-31. PubMed ID: 24561377
[TBL] [Abstract][Full Text] [Related]
17. Increased NT-proANP predicts risk of congestive heart failure in Cavalier King Charles spaniels with mitral regurgitation caused by myxomatous valve disease.
Eriksson AS; Häggström J; Pedersen HD; Hansson K; Järvinen AK; Haukka J; Kvart C
J Vet Cardiol; 2014 Sep; 16(3):141-54. PubMed ID: 25130405
[TBL] [Abstract][Full Text] [Related]
18. Plasma atrial and brain natriuretic peptide levels in dogs with congestive heart failure.
Asano K; Masuda K; Okumura M; Kadosawa T; Fujinaga T
J Vet Med Sci; 1999 May; 61(5):523-9. PubMed ID: 10379945
[TBL] [Abstract][Full Text] [Related]
19. Clinical utility of serum N-terminal pro-B-type natriuretic peptide concentration for identifying cardiac disease in dogs and assessing disease severity.
Oyama MA; Fox PR; Rush JE; Rozanski EA; Lesser M
J Am Vet Med Assoc; 2008 May; 232(10):1496-503. PubMed ID: 18479239
[TBL] [Abstract][Full Text] [Related]
20. Comparison of midregional pro-atrial natriuretic peptide with N-terminal pro-B-type natriuretic peptide in predicting survival in patients with chronic heart failure.
von Haehling S; Jankowska EA; Morgenthaler NG; Vassanelli C; Zanolla L; Rozentryt P; Filippatos GS; Doehner W; Koehler F; Papassotiriou J; Kremastinos DT; Banasiak W; Struck J; Ponikowski P; Bergmann A; Anker SD
J Am Coll Cardiol; 2007 Nov; 50(20):1973-80. PubMed ID: 17996563
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
